Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Targeted drug combination shows unprecedented activity in some highly aggressive brain tumors

WorldPharmaNewsNovember 26, 2021

Tag: Glioblastomas , dabrafenib , Brain Tumors

PharmaSources Customer Service